Literature DB >> 32446746

The Hippo Pathway as a Driver of Select Human Cancers.

Aishwarya Kulkarni1, Matthew T Chang2, Joseph H A Vissers3, Anwesha Dey2, Kieran F Harvey4.   

Abstract

The Hippo pathway regulates myriad biological processes in diverse species and is a key cancer signaling network in humans. Although Hippo has been linked to multiple aspects of cancer, its role in this disease is incompletely understood. Large-scale pan-cancer analyses of core Hippo pathway genes reveal that the pathway is mutated at a high frequency only in select human cancers, including malignant mesothelioma and meningioma. Hippo pathway deregulation is also enriched in squamous epithelial cancers. We discuss cancer-related functions of the Hippo pathway and potential explanations for the cancer-restricted mutation profile of core Hippo pathway genes. Greater understanding of Hippo pathway deregulation in cancers will be essential to guide the imminent use of Hippo-targeted therapies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo pathway; meningioma; mesothelioma; pan-cancer analysis

Mesh:

Substances:

Year:  2020        PMID: 32446746     DOI: 10.1016/j.trecan.2020.04.004

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  9 in total

Review 1.  Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing.

Authors:  Iwan Setiawan; Ardo Sanjaya; Ronny Lesmana; Paul M Yen; Hanna Goenawan
Journal:  J Physiol Biochem       Date:  2021-01-26       Impact factor: 4.158

2.  DNMBP-AS1 Regulates NHLRC3 Expression by Sponging miR-93-5p/17-5p to Inhibit Colon Cancer Progression.

Authors:  Lijie Yang; Tiecheng Yang; Huaqiao Wang; Tingting Dou; Xiaochang Fang; Liwen Shi; Xuanfei Li; Maohui Feng
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

3.  MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker.

Authors:  Xiang Jin; Lihua Zhu; Sheng Xiao; Zhuhong Cui; Jing Tang; Jiangyong Yu; Mingjun Xie
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

4.  Basic and Translational Models of Cooperative Oncogenesis.

Authors:  Helena E Richardson; Julia B Cordero; Daniela Grifoni
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 5.  Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy.

Authors:  Jin-Feng Xu; Yan Wan; Fei Tang; Lu Chen; Yu Yang; Jia Xia; Jiao-Jiao Wu; Hui Ao; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

6.  CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.

Authors:  Yuegui Guo; Zhehui Zhu; Zhenyu Huang; Long Cui; Wei Yu; Wanjin Hong; Zhaocai Zhou; Peng Du; Chen-Ying Liu
Journal:  Nat Commun       Date:  2022-08-25       Impact factor: 17.694

7.  PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells.

Authors:  Hui Xu; Wenjing Zhou; Fan Zhang; Linhui Wu; Juan Li; Tongtong Ma; Tong Cao; Chaoqun Lian; Jun Xia; Peter Wang; Jia Ma; Yuyun Li
Journal:  Cell Death Discov       Date:  2021-06-21

Review 8.  Sarcomatoid renal cell carcinoma: biology, natural history and management.

Authors:  Jose A Karam; A Ari Hakimi; Kyle A Blum; Sounak Gupta; Satish K Tickoo; Timothy A Chan; Paul Russo; Robert J Motzer
Journal:  Nat Rev Urol       Date:  2020-10-13       Impact factor: 14.432

Review 9.  Cellular feedback dynamics and multilevel regulation driven by the hippo pathway.

Authors:  Jiwon Park; Carsten Gram Hansen
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.